Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Shares Outstanding (Weighted Average) (2016)

Historic Shares Outstanding (Weighted Average) for Amphastar Pharmaceuticals (AMPH) over the last 4 years, with Q4 2016 value amounting to $46.1 million.

  • Amphastar Pharmaceuticals' Shares Outstanding (Weighted Average) rose 226.02% to $46.1 million in Q4 2016 from the same period last year, while for Dec 2016 it was $46.1 million, marking a year-over-year increase of 226.02%. This contributed to the annual value of $46.1 million for FY2016, which is 226.02% up from last year.
  • According to the latest figures from Q4 2016, Amphastar Pharmaceuticals' Shares Outstanding (Weighted Average) is $46.1 million, which was up 226.02% from $45.4 million recorded in Q3 2016.
  • In the past 5 years, Amphastar Pharmaceuticals' Shares Outstanding (Weighted Average) registered a high of $46.1 million during Q4 2016, and its lowest value of $38769.0 during Q1 2014.
  • Over the past 4 years, Amphastar Pharmaceuticals' median Shares Outstanding (Weighted Average) value was $44.6 million (recorded in 2015), while the average stood at $34.6 million.
  • In the last 5 years, Amphastar Pharmaceuticals' Shares Outstanding (Weighted Average) plummeted by 9989.73% in 2014 and then surged by 11494294.67% in 2015.
  • Amphastar Pharmaceuticals' Shares Outstanding (Weighted Average) (Quarter) stood at $38.7 million in 2013, then increased by 8.38% to $42.0 million in 2014, then rose by 7.46% to $45.1 million in 2015, then rose by 2.26% to $46.1 million in 2016.
  • Its Shares Outstanding (Weighted Average) was $46.1 million in Q4 2016, compared to $45.4 million in Q3 2016 and $45.0 million in Q2 2016.